[1]
Afladhanti, P.M. et al. 2022. Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2. SCRIPTA SCORE Scientific Medical Journal. 4, 1 (Sep. 2022), 30–43. DOI:https://doi.org/10.32734/scripta.v4i1.8399.